Sachdeva Ashwin, Veeratterapillay Rajan, Voysey Antonia, Kelly Katherine, Johnson Mark I, Aning Jonathan, Soomro Naeem A
Department of Urology, Freeman Hospital, Newcastle-upon-Tyne Hospitals NHS Foundation Trust, Newcastle-upon-Tyne, UK.
Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne, UK.
BMC Urol. 2017 Oct 2;17(1):91. doi: 10.1186/s12894-017-0262-y.
Positive surgical margins are a strong prognostic marker of disease outcome following radical prostatectomy, though prior evidence is largely from a PSA-screened population. We therefore aim to evaluate the biochemical recurrence in men with positive surgical margins (PSM) after minimally-invasive radical prostatectomy (MIRP) in a UK tertiary centre.
Retrospective study of men undergoing laparoscopic or robotic-assisted radical prostatectomy between 2002 and 2014. Men with positive surgical margins (PSM) were identified and their biochemical recurrence (BCR) rate compared with men without PSM. The primary outcome measures were BCR rates and time to BCR. Cox regression was used to estimate adjusted hazard ratios for biochemical recurrence rate (BCR), accounting for potential confounders.
Five hundred ninety-two men were included for analysis. Pre-operative D'Amico risk stratification showed 37.5%, 53.3% and 9.3% of patients in the low, intermediate and high-risk groups, respectively. On final pathological analysis, the proportion of patients with local staging pT2, pT3a and pT3b was 68.8%, 25.2% and 6.1% respectively. Overall positive margin rate was 30.6%. On multivariate analysis, the only pre-operative factor associated with PSM was age >65years. Patients with PSM were more likely to have higher tumour volume and more advanced pathological local stage. The BCR rate was 10.7% in margin-positive patients and 5.1% in margin-negative patients, at median 4.4-year follow-up. Upon multivariate analysis, high pre-operative PSA and high Gleason group were the only significant predictors of BCR (P<0.05).
In comparison to patients with negative surgical margins, those with PSM do not translate into worse medium-term oncological outcomes in the majority of cases amongst our cohort. We found that high pre-operative PSA and high Gleason group were the only significant predictors of BCR.
手术切缘阳性是根治性前列腺切除术后疾病转归的一个重要预后指标,不过先前的证据大多来自前列腺特异性抗原(PSA)筛查人群。因此,我们旨在评估英国一家三级中心行微创根治性前列腺切除术(MIRP)后手术切缘阳性(PSM)男性患者的生化复发情况。
对2002年至2014年间接受腹腔镜或机器人辅助根治性前列腺切除术的男性患者进行回顾性研究。确定手术切缘阳性(PSM)的患者,并将其生化复发(BCR)率与无PSM的患者进行比较。主要结局指标为BCR率和至BCR的时间。采用Cox回归估计生化复发率(BCR)的调整风险比,同时考虑潜在的混杂因素。
592名男性纳入分析。术前D'Amico风险分层显示,低、中、高危组患者分别占37.5%、53.3%和9.3%。最终病理分析显示,局部分期为pT2、pT3a和pT3b的患者比例分别为68.8%、25.2%和6.1%。总体切缘阳性率为30.6%。多因素分析显示,与PSM相关的唯一术前因素是年龄>65岁。PSM患者更有可能具有更高的肿瘤体积和更晚期的病理局部分期。中位随访4.4年时,切缘阳性患者的BCR率为10.7%,切缘阴性患者为5.1%。多因素分析显示,术前高PSA和高Gleason分级是BCR的唯一显著预测因素(P<0.05)。
与手术切缘阴性的患者相比,在我们的队列中,大多数情况下,PSM患者并未转化为更差的中期肿瘤学结局。我们发现术前高PSA和高Gleason分级是BCR的唯一显著预测因素。